Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FYLF7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,293
Award facts
- Contract value 100% obligated
- $16,292.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $16,292.52 delivery order to Amerisourcebergen Drug Corp on May 13, 2026, for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml pharmaceutical supply under a firm fixed-price structure. Ultimate completion is May 14, 2026.
Place of performance is Conshohocken, PA. The order carries no set-aside designation and reflects transactional pharmaceutical procurement typical of Amerisourcebergen's sustained position on DLA Troop Support Medical indefinite delivery contracts serving military healthcare supply chains globally.
Quick answers
Who was awarded contract SPE2DR26FYLF7?
SPE2DR26FYLF7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 13, 2026.
How much is contract SPE2DR26FYLF7 worth?
The government has obligated $16,293 on SPE2DR26FYLF7.
Is contract SPE2DR26FYLF7 an order under another contract?
Yes. SPE2DR26FYLF7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FYLF7 competed?
The extent of competition for SPE2DR26FYLF7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award